Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease Patients

NCT01220115 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01220115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease Patients
Lead sponsor
Novartis
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
September 30, 2014
Enrollment
498 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease